{rfName}
Co

Indexed in

License and use

Altmetrics

Analysis of institutional authors

De Miguel Mendieta, EugenioAuthorMulero Mendoza, JuanAuthorSanz Sanz, JesusAuthor

Share

August 19, 2020
Publications
>
Article
No

Consenso ASAS en nomenclatura en español para las espondiloartritis

Publicated to:Reumatologia Clinica. 16 (5): 333-338 - 2020-09-01 16(5), DOI: 10.1016/j.reuma.2018.07.014

Authors: Navarro Compán, Victoria; Otón Sánchez, María Teresa; Loza Santamaría, Estíbaliz; Almodóvar González, Raquel; Ariza Ariza, Rafael; Bautista-Molano, Wilson; Burgos Vargas, Rubén; Collantes Estévez, Eduardo; Miguel Mendieta, Eugenio de; González, Carlos; Gratacós Masmitjà, Jordi; Ibáñez, Sebastián; Juanola Roura, Xavier; Maldonado-Cocco, José A; Moltó Revilla, Anna; Mulero Mendoza, Juan; Pacheco Tena, César; Ramos Remus, César; Sanz Sanz, Jesús; Valle, Rafael; Zarco Montejo, Pedro; Marzo-Ortega, Helena

Affiliations

Clínica Colombiana de Reumatología-Salud Reinun - Author
Facultad de Medicina de la Universidad de Chile - Author
Fundación Hospital Alcorcón - Author
Hopital Cochin AP-HP - Author
Hospital General de Mexico - Author
Hospital General Universitario Gregorio Marañón - Author
Hospital Universitari de Bellvitge - Author
Hospital Universitario La Paz - Author
Hospital Universitario Puerta de Hierro - Author
Hospital Universitario Reina Sofía - Author
Hospital Universitario Virgen Macarena - Author
Instituto de Salud Musculoesquelética - Author
Unidad de Investigación Médica en Enfermedades Neurológicas - Author
Universidad Autonoma de Chihuahua - Author
Universidad de Buenos Aires - Author
Universidad Militar Nueva Granada - Author
University of Leeds - Author
See more

Abstract

To develop a consensus to standardize the use of Spanish terms, abbreviations and acronyms in the field of spondyloarthritis (SpA).An international task force comprising all native Spanish-speaking Assessment of SpondyloArthritis International Society (ASAS) members, the executive committee of Grupo para el estudio de la Espondiloartritis de la Sociedad Española de Reumatología (GRESSER), two methodologists, two linguists from the Real Academia Nacional de Medicina de España (RANM) and two patients from the Spanish Coordinator of Spondylitis Associations (CEADE) was established. A literature review was performed to identify the conflicting terms/abbreviations/acronyms in SpA. This review examined written sources in Spanish including manuscripts, ICF and ICD, guidelines, recommendations and consensuses. This was followed by a nominal group meeting and a three-round Delphi. The recommendations from the RANM based on the Panhispanic dictionary were followed throughout the process.Consensus was reached for 46 terms, abbreviations or acronyms related to the field of SpA. A Spanish translation was accepted for 6 terms and 6 abbreviations to name or classify the disease, and for 6 terms and 4 abbreviations related to SpA. It was agreed not to translate 15 acronyms into Spanish. However, when mentioning them, it was recommended to follow this structure: type of acronym in Spanish and acronym and expanded form in English. With regard to 7 terms or abbreviations attached to acronyms, it was agreed to translate only the expanded form and a translation was also selected for each of them.Through this standardization, it is expected to establish a common use of the Spanish nomenclature for SpA. The implementation of this consensus across the community will be of substantial benefit, avoiding misunderstandings and time-consuming processes.Copyright © 2018 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Keywords

abbreviationabreviaturaacrónimoacronymespondiloartritisnomenclaturanomenclatureAbbreviationAbreviaturaAcrónimoAcronymEspondiloartritisNomenclaturaNomenclatureSpondyloarthritis

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Reumatologia Clinica, Q4 Agency Scopus (SJR), its regional focus and specialization in Rheumatology, give it significant recognition in a specific niche of scientific knowledge at an international level.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 5.68, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Aug 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-08-03, the following number of citations:

  • WoS: 1
  • Scopus: 5

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-08-03:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 29.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 50 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 21.65.
  • The number of mentions on the social network X (formerly Twitter): 27 (Altmetric).
  • The number of mentions on Wikipedia: 2 (Altmetric).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Argentina; Chile; Colombia; Granada; Mexico.